Description
GLP-3 (RT) is a synthetic triple-agonist peptide designed to engage the GIP, GLP-1 and glucagon receptors simultaneously. This combined receptor activity has made it a subject of preclinical incretin-receptor pharmacology research.
Supplied as a lyophilized powder for in-vitro laboratory research, each batch is HPLC-verified to 99%+ purity and shipped with a Certificate of Analysis. Intended for in vitro and laboratory research applications only.
Research highlights
- Investigated as a unimolecular triple incretin-receptor agonist
- Characterized in published receptor-pharmacology research
- 39-amino-acid peptide backbone
Specifications
| Purity | 99%+ (HPLC verified) |
|---|---|
| Form | Lyophilized powder |
| COA | Included with every batch |
| Storage | Store lyophilized at -20°C; protect from light |
| Sequence length | 39 amino acids |
| Also known as | LY3437943 |
For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic procedures.
Compound Information
What is GLP-3 (RT)?
| Type | Synthetic peptide |
|---|---|
| CAS Number | 2381089-83-2 |
| Molecular Weight | 4,731 g/mol |
| Amino Acids | 39 |
| Fatty Acid Chain | C20 diacid |
Sources & References
Independent peer-reviewed literature, provided for scientific reference. These are not claims about this product.
- New England Journal of MedicineTriple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 TrialView source ↗







Reviews
There are no reviews yet.